Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$845K Buy
2,713
+58
+2% +$17.1K 0.48% 58
2024
Q4
$692K Buy
2,655
+1,059
+66% +$314K 0.41% 70
2024
Q3
$514K Buy
1,596
+299
+23% +$97.8K 0.36% 85
2024
Q2
$405K Buy
1,297
+83
+7% +$24.4K 0.33% 88
2024
Q1
$333K Sell
1,214
-30
-2% -$8.78K 0.32% 90
2023
Q4
$358K Buy
+1,244
New +$339K 0.36% 84

Other funds holding AMGN

Napatree Capital's AMGN Position: Q1 2025 in Review

Napatree Capital increased its Amgen (AMGN) stake by 2.2% in Q1 2025, buying an estimated $17.1K and bringing the position to 2,713 shares worth $845K. The position accounts for 0.48% of the portfolio, ranked #58.

Napatree Capital first reported a position in AMGN in Q4 2023 and has held it in 6 quarters since. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Napatree Capital held 2,713 shares of Amgen worth $845K as of Q1 2025.
  • Napatree Capital bought 58 Amgen shares in Q1 2025, an estimated $17.1K.
  • Amgen made up 0.48% of Napatree Capital's portfolio in Q1 2025, its #58 holding.
  • Napatree Capital first reported a position in Amgen in Q4 2023 and has held it in 6 quarters since.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Napatree Capital's 13F filing for Q1 2025, filed 2 May 2025.